Cold Spring Harbor, NY, United States of America

Paramjit S Arora

USPTO Granted Patents = 25 (Patent Applications = 10)

EPO Patents = 5 (Patent Applications = 12)

Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 271(Granted Patents)

Location History:

New York, NY (US) (2007 - 2011)
White Plains, NY (US) (2010 - 2014)
Huntington, NY (US) (2015 - 2016)
Cold Spring Harbor, NY (US) (2015 - 2024)

Company Filing History:

The Ohio State University

patents

2 out of 3,390

University of Michigan

patents

4. 1 out of 44

Aileron Therapeutics, Inc.

patents

5. 1 out of 1,636

University of Southern California

patents

6. 1 out of 975

The University of Arizona

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371461 - Nemo coiled coil mimics and methods of using same (2025-07-29),

2. 11891422 - NEMO coiled coil mimics and methods of using same (2024-02-06),

3. 11560359 - Oxopiperazine helix mimetics for control of hypoxia-inducible gene expression (2023-01-24),

4. 11440938 - Stabilized minimal coiled-coil mimetics (2022-09-13),

5. 11180481 - Oxopiperazine helix mimetics as inhibitors of the p53-MDM2 interaction (2021-11-23),

6. 10851133 - Stabilized minimal coiled-coil mimetics (2020-12-01),

7. 10787424 - Oxopiperazine helix mimetics for control of Hypoxia-Inducible gene expression (2020-09-29),

8. 10221215 - Hydrogen bond surrogate macrocycles as modulators of Ras (2019-03-05),

9. 9783526 - Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics (2017-10-10),

10. 9695153 - Oligooxopiperazines for p53 reactivation (2017-07-04),

11. 9624203 - Oligooxopiperazines and methods of making and using them (2017-04-18),

12. 9605026 - Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation (2017-03-28),

13. 9593142 - Aldehyde capture ligation technology for synthesis of amide bonds (2017-03-14),

14. 9399666 - Inhibiting interaction between the HIF-1ALPHA and p300/CBP with hydrogen bond surrogate-based helices (2016-07-26),

15. 9376469 - Proteolytically resistant hydrogen bond surrogate helices (2016-06-28),

Title: Paramjit S Arora: Pioneering Innovator in the Field of Bioinspired Pharmaceuticals

Introduction

Paramjit S Arora, a distinguished inventor based in Cold Spring Harbor, NY, has made significant contributions to the field of bioinspired pharmaceuticals. With an impressive portfolio of 24 patents, Arora's innovative work has led to groundbreaking developments in the industry.

Latest Patents

Among his latest patents is the cutting-edge invention of NEMO coiled coil mimics. This revolutionary macrostructure, along with pharmaceutical formulations containing it, showcases a parallel coiled-coil structure that has the potential to transform the field. Additionally, Arora's invention of oxopiperazine helix mimetics for controlling hypoxia-inducible gene expression demonstrates his commitment to pioneering new pathways in pharmaceutical research.

Career Highlights

Arora's impactful career has seen him collaborate with renowned institutions such as New York University and The Ohio State University Research Foundation. His tenure at these institutions has been marked by a relentless pursuit of innovation, resulting in numerous groundbreaking discoveries that have shaped the industry.

Collaborations

Throughout his career, Arora has worked closely with talented individuals such as Brooke Bullock Lao and Ross N Chapman. These collaborations have been instrumental in bringing his visionary ideas to life and driving forward advancements in the field of bioinspired pharmaceuticals.

Conclusion

Paramjit S Arora's trailblazing work as an inventor and researcher has solidified his position as a pioneering figure in the realm of bioinspired pharmaceuticals. With a focus on innovation and collaboration, Arora continues to push the boundaries of what is possible in the field, leaving a lasting impact on the industry and beyond.

This text is generated by artificial intelligence and may not be accurate.